LY3202328

· Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LY3202328, covering 2021-05-25 to 2021-05-25. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate LY3202328 in Overweight Healthy Participants and Dyslipidemia [Phase 1]